Literature DB >> 10691231

Hypoxic brain tissue following subarachnoid hemorrhage.

W E Hoffman1, P Wheeler, G Edelman, F T Charbel, N J Torres, J I Ausman.   

Abstract

BACKGROUND: Subarachnoid hemorrhage can lead to cerebral ischemia and irreversible brain injury. The purpose of this study was to determine whether subarachnoid hemorrhage produces changes in brain tissue oxygen pressure, carbon dioxide pressure, or pH during surgery for cerebral aneurysm clipping.
METHODS: After institutional review board approval and patient consent, 30 patients undergoing craniotomy for cerebral aneurysm clipping were studied, 15 without and 15 with subarachnoid hemorrhage. Patients with subarachnoid hemorrhage were prospectively separated into groups with modest (Fisher grade 1 or 2; n = 8) and severe bleeds (Fisher grade 3; n = 7). After a craniotomy, a probe was inserted into cortex tissue supplied by the artery associated with the aneurysm. Baseline measures were made in the presence of a 4% end-tidal desflurane level. The end-tidal desflurane level was increased to 9% before clipping of the aneurysm, and a second tissue measurement was made.
RESULTS: The median time of surgery after subarachnoid hemorrhage was 2 days, ranging from 1 to 13 days. During baseline anesthesia, brain tissue oxygen pressure was 17+/-9 mm Hg (mean +/- SD) in control patients, 13+/-9 mm Hg in those with Fisher grade 1 or 2 hemorrhage, and 7+/-6 mm Hg in those with Fisher grade 3 hemorrhage (P<0.05 compared with control). Brain tissue pH was 7.10+/-0.10 in control patients, 7.14+/-0.13 in those with Fisher grade 1 or 2 hemorrhage, and 6.95+/-0.18 in those with with Fisher grade 3 hemorrhage (P<0.05). At a 9% end-tidal desflurane level, brain tissue oxygen pressure increased to 19+/-9 mm Hg and brain tissue pH increased to 7.11+/-0.11 in patients with Fisher grade 3 hemorrhage (P<0.05 for both increases).
CONCLUSION: These results show that subarachnoid hemorrhage can significantly decrease brain tissue oxygen pressure and pH related to the severity of the bleed. Increasing the desflurane concentration to 9% increased brain tissue oxygen pressure in all patients and brain tissue pH in patients with subarachnoid hemorrhage with baseline acidosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691231     DOI: 10.1097/00000542-200002000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin.

Authors:  Casper Hempel; Valery Combes; Nicholas Henry Hunt; Jørgen Anders Lindholm Kurtzhals; Georges Emile Raymond Grau
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

2.  Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection.

Authors:  P Miller; P J Kemp; A Lewis; C G Chapman; H J Meadows; C Peers
Journal:  J Physiol       Date:  2003-02-28       Impact factor: 5.182

3.  Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.

Authors:  Robert P Ostrowski; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-09-01       Impact factor: 6.829

4.  Beneficial Effect of Sodium Nitrite on EEG Ischaemic Markers in Patients with Subarachnoid Haemorrhage.

Authors:  Alexander Luettich; Edit Franko; Desiree B Spronk; Catherine Lamb; Rufus Corkill; Jash Patel; Martyn Ezra; Kyle T S Pattinson
Journal:  Transl Stroke Res       Date:  2021-09-07       Impact factor: 6.829

Review 5.  Monitoring of brain and systemic oxygenation in neurocritical care patients.

Authors:  Mauro Oddo; Julian Bösel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

6.  Endogenous zinc protoporphyrin formation critically contributes to hemorrhagic stroke-induced brain damage.

Authors:  Rong Pan; Song Yu; Haikun Zhang; Graham S Timmins; John Weaver; Yirong Yang; Xixi Zhou; Ke Jian Liu
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-29       Impact factor: 6.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.